1,429 reports of this reaction
4.0% of all DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE reports
#3 most reported adverse reaction
FATIGUE is the #3 most commonly reported adverse reaction for DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE, manufactured by Pfizer Laboratories Div Pfizer Inc. There are 1,429 FDA adverse event reports linking DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE to FATIGUE. This represents approximately 4.0% of all 35,651 adverse event reports for this drug.
Patients taking DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE who experience fatigue should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
FATIGUE is moderately reported among DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE users, representing a notable but not dominant share of adverse events.
In addition to fatigue, the following adverse reactions have been reported for DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE:
The following drugs have also been linked to fatigue in FDA adverse event reports:
FATIGUE has been reported as an adverse event in 1,429 FDA reports for DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE. This does not prove causation, but indicates an association observed in post-market surveillance data.
FATIGUE accounts for approximately 4.0% of all adverse event reports for DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE, making it one of the most commonly reported side effect.
If you experience fatigue while taking DIPHENOXYLATE HYDROCHLORIDE AND ATROPINE SULFATE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.